Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Gynecol Endocrinol. 2022 Mar;38(3):238-242. doi: 10.1080/09513590.2021.1955342. Epub 2021 Aug 12.
Frozen embryo transfer (FET) is associated with a higher risk of hypertensive disorders in pregnancy. The objective of the present study is to evaluate the effect of different protocols of endometrial preparation on the risk of these disorders.
We conducted a retrospective cohort study on 594 singleton pregnancies achieved by embryo transfer of single frozen-thawed blastocysts. Women with preexisting risk factors for hypertensive disorders were excluded. Women were divided into two groups according to the endometrial preparation protocol: either natural cycle ( = 495) or programming cycle with hormonal replacement therapy ( = 97). The primary outcome was the frequency of hypertensive disorders in pregnancy: specifically, gestational hypertension and preeclampsia.
No differences emerged between women following the natural cycle and those following the programming cycle in the frequency of gestational hypertension (5 4%) and preeclampsia (1.1 1.2%). No impact emerged also after multivariate analyses.
Women receiving hormonal replacement therapy have the same risk of gestational hypertension and preeclampsia as women following natural cycles when considering low-risk singleton pregnancies.
冻融胚胎移植(FET)与妊娠高血压疾病的风险增加相关。本研究旨在评估不同的子宫内膜准备方案对这些疾病风险的影响。
我们对 594 例通过单个冷冻-解冻囊胚移植实现的单胎妊娠进行了回顾性队列研究。排除有妊娠高血压疾病既往风险因素的妇女。根据子宫内膜准备方案将妇女分为两组:自然周期组(n=495)或激素替代治疗方案组(n=97)。主要结局是妊娠高血压疾病的发生率:具体为妊娠期高血压和子痫前期。
自然周期组和方案周期组在妊娠期高血压(5.4%)和子痫前期(1.1%比 1.2%)的发生率方面无差异。多变量分析后也未出现影响。
在考虑低风险单胎妊娠时,接受激素替代治疗的妇女与自然周期组妇女一样,有发生妊娠期高血压和子痫前期的相同风险。